"Natural Medicine Extractors"
Calgary, Alberta – February 17, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) announces SHAMAN’s mHealth machine-learning progress and proposed financing details. MXT reports that the SHAMAN development is ahead of schedule and under budget. Medxtractor originally planned for completion of Phase 1 by April but hard work has resulted in early success allowing for…
Read more
Calgary, Alberta – January 19, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) updates the SHAMAN psychedelics project and extractor operations. The Company reports that the initial specification for the SHAMAN division’s psychedelics project has progressed to the point that the proof-of-concept (“POC”) phase can begin. Jim Durward, President, states: “We have recently acquired EEG…
Read more
Calgary, Alberta – January 4, 2021. For Immediate Release – Medxtractor Corp. (“MXT”) initiates a market visibility program. Effective immediately, MXT has engaged Stockhouse Publishing Ltd. to provide market visibility services over an initial four-month period at a cost of $40,000. MXT has also engaged D’Arcy Funfer, an investor relations professional, at $2500/month on a…
Read more
Calgary, Alberta – December 31, 2020. For Immediate Release – Medxtractor Corp. (“MXT”) announces commencement of “SHAMAN”, a large-scale multi-phase database development and commercialization project focusing on the application of psychedelics and psychotropics to mental health afflictions. SHAMAN is designed to use artificial intelligence (“AI”) to predict the impact of psychedelics and psychotropics on mental…
Read more
Calgary, Alberta – December 29, 2020. MedXtractor Corp. (CSE: MXT) (“MXT” or the “Corporation”) announces its financial results for the quarter ended November 30, 2020 (fiscal Q3, 2021). MXT had gross revenues of $185,829 and net operating loss of $18,814 for the quarter ended November 30, 2020 (fiscal Q3, 2021). Year-to-date gross revenues of $448,592…
Read more
MEDXTRACTOR ANNOUNCES CORPORATE UPDATE Calgary, Alberta – December 3, 2020. Medxtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) is pleased to provide an operational update for the quarter ended November 30, 2020 (Q3, Fiscal 2021). Jim Durward, President, states: “During the quarter, and as of today, there have been some very positive developments in the…
Read more
Calgary, Alberta – November 4, 2020. Medxtractor Corp. (CSE: MXT) (“Medx” or the “Corporation”) announces that Neil A. Runions has resigned as a director of the Corporation and Gordon Neil Crawford has been appointed to the board of directors effective November 4, 2020. The current Board is now comprised of James M. Durward, G. Steven…
Read more
Jim Durward states: “On September 8, 2020, Infection Control Today published an article by Kevin Kavanagh, MD in which Dr. Kavanagh states: “Several recent studies have supported the growing hypothesis that coronavirus disease 2019 (COVID-19) is primarily a cardiovascular, and not a pulmonary virus. The narrative that those affected are usually asymptomatic and have very…
Read more
Calgary, Alberta – September 29, 2020. MedXtractor Corp. (CSE: MXT) (“MXT” or the “Corporation”) announces its financial results for the quarter ended August 31, 2020 (fiscal Q2, 2021). MXT had gross revenues of $167,270 and net income of $16,556 for the quarter ended August 31, 2020 (fiscal Q2, 2021). Year-to-date gross revenues of $262,763 and…
Read more
James Durward reports: “I am pleased to announce that Medxtractor has been awarded Canadian patent number CA 2977305 for it’s CO2-based extraction process. This is a follow-on patent for the previously granted US patent and I believe that these patents help secure the small grower horizontal that MXT serves. When combined with our recently released…
Read more
Recent Comments